Original articleWomen and mexican Americans receive fewer cardiovascular drugs following myocardial infarction than men and non-hispanic whites: The Corpus Christi Heart Project, 1988–1990☆
References (42)
Secondary prevention after myocardial infarction
Lancet
(1986)- et al.
Hospitalization rates for myocardial infarction among Mexican Americans and non-Hispanic whites: the Corpus Christi Heart Project
Ann Epidemiol
(1993) - et al.
International diagnostic criteria for acute myocardial infarction and acute stroke
Am Heart J
(1984) The secondary prevention of myocardial infarction by drug treatments, excluding lipid-lowering agents
Clin Exp Hypertens
(1992)Secondary prevention in myocardial infarction survivors
Circulation
(1980)Secondary prevention after myocardial infarction: facts and fallacies
J Cardiovasc Pharmacol
(1984)- et al.
Risk factor modification after myocardial infarction
Ann Int Med
(1988) The case for beta-blockers as first-line antihypertensive therapy (suppl)
J Hypertens
(1992)- et al.
Noninvasive and invasive strategies for the prevention of sudden death after myocardial infarction. Value, limitations and implications for therapy
Drugs
(1992) - et al.
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction—results of the Survival and Ventricular Enlargement Trial
N Engl J Med
(1992)
Effect of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril survival Study (CONSENSUS)
N Engl J Med
(1987)
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
N Engl J Med
(1991)
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
N Engl J Med
(1991)
Prevention of myocardial infarction
Am J Cardiol
(1992)
Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults
Arch Intern Med
(1988)
The cholesterol facts: a summary of evidence relating dietary fats, serum cholesterol, and coronary heart disease: a joint statement by the American Heart Association and the National Heart, Lung and Blood Institute
Circulation
(1990)
Overview of results of randomized clinical trials in heart disease. II) Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification
JAMA
(1988)
Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall Study
Brit Med J
(1986)
The value of lowering cholesterol after myocardial infarction
N Engl J Med
(1990)
Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary disease
N Engl J Med
(1987)
Cited by (0)
- ☆
This investigation was supported by Grant Number HL38429, awarded by the National Heart, Lung, and Blood Institute, and by a grant awarded by the German Academic Exchange Service (DAAD), Bonn, Germany.
Copyright © 1996 Published by Elsevier Inc.